Abstract
Cancer is one of the leading causes of death worldwide. Current chemotherapy challenges the lack of selectivity, cytotoxicity, the development of multi-drug resistance, and the proliferation of stem-like cells. One of the leading causes of new cancer cases and cancer-related fatalities is a group of deadly malignant tumors known as liver and gastric cancer. Advanced gastric cancer is classified as having liver metastases and is one of the deadliest conditions with a dismal prognosis. As gastric cancer with liver metastases is incurable, systematic chemotherapy is the primary line of treatment, although surgery is typically used to relieve severe gastrointestinal symptoms. The main method for delivering various medications, nucleic acids, and imaging agents is nanoemulsion (NE). Nevertheless, NE is created through many functions, including surface changes and the encapsulation of active cancer-fighting substances. Because of their excellent characteristics to solubilize hydrophobic chemotherapeutics, thermodynamic stability, biocompatibility, and target ability, NEs are an appealing platform for cancer treatment. With their submicron-dispersed colloids in the continuous phase, NEs may be able to perform various tasks, which helps to overcome biological obstacles that prevent traditional chemotherapeutic drug delivery from reaching the target location of cancers. This chapter provides a brief overview of the use of NEs in treating gastric and liver cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdu F, Alshehri W, Alkhatib MH (2017) The anticancer activity of the combination therapy of gem and dox encapsulated in a NE. Polym Sci 3(4). https://doi.org/10.4172/2471-9935-C1-006
Abu-Fayyad A, Nazzal S (2017) Gem-Vitamin E conjugates: synthesis, characterization, entrapment into NEs, and in-vitro deamination and antitumor activity. Int J Pharm 528(1–2):463. https://doi.org/10.1016/J.IJPHARM.2017.06.031
Ahmad U, Akhtar J, Singh SP, Badruddeen B, Ahmad FJ, Siddiqui S, Wahajuddin W (2018) Silymarin NE against human hepatocellular carcinoma: development and optimization. Artif Cells, Nanomed Biotechnol 46(2):231–241. https://doi.org/10.1080/21691401.2017.1324465
Alavizadeh SH, Hosseinzadeh H (2014) Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol: Int J Publ Brit Indus Biol Res Assoc 64:65–80. https://doi.org/10.1016/J.FCT.2013.11.016
Alkhatib MH, Alkreathy HM, Balamash KS, Abdu F (2016) Antitumor activity of doxe-loaded NE against ehrlich ascites carcinoma-bearing mice. Trop J Pharm Res 15(5):937–943. https://doi.org/10.4314/TJPR.V15I5.6
Alkhatib MH, Alshehri WS, Abdu FB (2018) In vivo evaluation of the anticancer activity of the gem and dox combined in a NE. J Pharm Bioallied Sci 10(1):35–42. https://doi.org/10.4103/JPBS.JPBS_225_17
Alnajjar AsmaM, Elsiesy HussienA (2015) Natural products and hepatocellular carcinoma: a review. Hepatoma Res 1(3):119. https://doi.org/10.4103/2394-5079.167379
Cao H, Wang Y, He X, Zhang Z, Yin Q, Chen Y, Yu H, Huang Y, Chen L, Xu M, Gu W, Li Y (2015) Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma. Mol Pharm 12(3):922–931. https://doi.org/10.1021/MP500755J
Choudhury H, Pandey M, Gorain B, Chatterjee B, Madheswaran T, Mak SMKK, Tambuwala M, Chourasia MK, Kesharwani P (2019) NEs as effective carriers for the treatment of lung cancer. Nanotechnol-Based Target Drug Deliv Syst Lung Cancer 217–247. https://doi.org/10.1016/B978-0-12-815720-6.00009-5
Efferth T (2017) From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 46:65–83. https://doi.org/10.1016/J.SEMCANCER.2017.02.009
El-Readi MZ, Althubiti MA (2019) Cancer nanomedicine: a new era of successful targeted therapy. J Nanomater. https://doi.org/10.1155/2019/4927312
El-Sherbiny M, Eldosoky M, El-Shafey M, Othman G, Elkattawy HA, Bedir T, Elsherbiny NM (2018) Vitamin D NE enhances hepatoprotective effect of conventional Vitamin D in rats fed with a high-fat diet. Chem Biol Interact 288:65–75. https://doi.org/10.1016/J.CBI.2018.04.010
Esperón-Rojas AA, Baeza-Jiménez R, Cano-Sarmiento C, GarcÃa HS (2017) Structured mono- and diacylglycerols with a high content of medium chain fatty acids. J Oleo Sci 66(9):991–996. https://doi.org/10.5650/JOS.ESS17010
Esperón-Rojas, Alessa A, Baeza-Jiménez R, GarcÃa HS (2019) Preparation of curcumin-carrying NEs using mono- and diacylglycerides enzymatically structured with bioactive fatty acids. 38(2):93–103. https://doi.org/10.1080/10242422.2019.1646254
Fan M, Liang X, Li Z, Wang H, Yang D, Shi B (2015) Chlorambucil gem conjugate nanomedicine for cancer therapy. Eur J Pharm Sci: Off J Eur Federat Pharm Sci 79:20–26. https://doi.org/10.1016/J.EJPS.2015.08.013
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/IJC.29210
Ganta S, Talekar M, Singh A, Coleman TP, Amiji MM (2014) NEs in translational research-opportunities and challenges in targeted cancer therapy. AAPS PharmSciTech 15(3):694–708. https://doi.org/10.1208/S12249-014-0088-9
Gorain B, Choudhury H, Nair AB, Dubey SK, Kesharwani P (2020) Theranostic application of NEs in chemotherapy. Drug Discov Today 25(7):1174–1188. https://doi.org/10.1016/J.DRUDIS.2020.04.013
Herneisey M, Mejia G, Pradhan G, Dussor G, Price T, Janjic J (2018) Resveratrol NEs target inflammatory macrophages to prevent. J Pain 19(3):S75-76. https://doi.org/10.1016/j.jpain.2017.12.173
Izadiyan Z, Basri M, Masoumi HRF, Karjiban RA, Salim N, Shameli K (2017) Modeling and optimization of NE containing sorafenib for cancer treatment by response surface methodology. Chem Central J 11(1). https://doi.org/10.1186/S13065-017-0248-6
Jaganathan SK, Mazumdar A, Mondhe D, Mandal M (2011) Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35(6):607–615. https://doi.org/10.1042/CBI20100118
Jaiswal M, Dudhe R, Sharma PK (2015) NE: an advanced mode of drug delivery system. 3 Biotech 5(2):123. https://doi.org/10.1007/S13205-014-0214-0
Kentish S, Wooster TJ, Ashokkumar M, Balachandran S, Mawson R, Simons L (2008) The use of ultrasonics for NE preparation. Innov Food Sci Emerg Technol 9(2):170–175. https://doi.org/10.1016/J.IFSET.2007.07.005
Kim S, Choi MG, Lee HS, Lee SK, Kim SH, Kim WW, Hur SM, Kim JH, Choe JH, Nam SJ, Yang JH, Kem S, Lee JE, Kim JS (2009) Silibinin suppresses TNF-α-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway. Molecules 14(11):4300–4311. https://doi.org/10.3390/MOLECULES14114300
Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G (2021) Nanotechnology approaches for global infectious diseases. Nat Nanotechnol 16(4):369–384. https://doi.org/10.1038/s41565-021-00866-8
Li JH, Xie XY, Zhang L, Le F, Ge NL, Li LX, Gan YH, Chen Y, Zhang JB, Xue TC, Chen RX, Xia JL, Zhang BH, Ye SL, Wang YH, Ren ZG (2015) Oxaliplatin and 5-FU hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. World J Gastroenterol: WJG 21(13):3970. https://doi.org/10.3748/WJG.V21.I13.3970
Ligeret H, Brault A, Vallerand D, Haddad Y, Haddad PS (2008) Antioxidant and mitochondrial protective effects of silibinin in cold preservation-warm reperfusion liver injury. J Ethnopharmacol 115(3):507–514. https://doi.org/10.1016/J.JEP.2007.10.024
Luo Z, Rong Z, Huang C (2019) Surgery strategies for gastric cancer with liver metastasis. Front Oncol 9. https://doi.org/10.3389/FONC.2019.01353
Majeed H, Antoniou J, Fang Z (2014) Apoptotic effects of eugenol-loaded NEs in human colon and liver cancer cell lines. Asian Pac J Cancer Prevent: APJCP 15(21):9159–9164. https://doi.org/10.7314/APJCP.2014.15.21.9159
Mehrnia MA, Jafari SM, Makhmal-Zadeh BS, Maghsoudlou Y (2016) Crocin loaded nano-emulsions: factors affecting emulsion properties in spontaneous emulsification. Int J Biol Macromol 84:261–267. https://doi.org/10.1016/J.IJBIOMAC.2015.12.029
Mohapatra P, Chandrasekaran N, Mukherjee A (2021) NE: a boon to liver and gastric cancer treatment (May):307–329. https://doi.org/10.4018/978-1-7998-8378-4.ch014
Naseema A, Kovooru L, Behera AK, Kumar KPP, Srivastava P (2021) A critical review of synthesis procedures, applications and future potential of NEs. Adv Colloid Interf Sci 287:102318. https://doi.org/10.1016/J.CIS.2020.102318
Noureini SK, Wink M (2012) Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and HTERT down-regulation. Asian Pac J Cancer Prevent: APJCP 13(5):2305–2309. https://doi.org/10.7314/APJCP.2012.13.5.2305
Pangeni R, Choi SW, Jeon OC, Byun Y, Park JW (2016) Multiple NE system for an oral combinational delivery of oxaliplatin and 5-FU: preparation and in vivo evaluation. Int J Nanomed 11:6379. https://doi.org/10.2147/IJN.S121114
Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting CAMP phosphodiesterases. Cell 148(3):421–433. https://doi.org/10.1016/J.CELL.2012.01.017
Plaza-Oliver M, Santander-Ortega MJ, Lozano MV (2021) Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res 11(2):471–497. https://doi.org/10.1007/S13346-021-00908-7
Praveen Kumar G, Divya A (2015) NE based targeting in cancer therapeutics. Med Chem, Open Access J 5(6):272–284. https://doi.org/10.4172/2161-0444.1000275
Pucek A, Tokarek B, Waglewska E, Bazylińska U (2020) Recent advances in the structural design of photosensitive agent formulations using ‘Soft’ colloidal nanocarriers. Pharmaceutics 12(6):587. https://doi.org/10.3390/PHARMACEUTICS12060587
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77(6):1598–1606. https://doi.org/10.1016/j.jhep.2022.08.021
Sánchez-López E, Guerra M, Dias-Ferreira J, Lopez-Machado A, Ettcheto M, Cano A, Espina M, Camins A, Garcia ML, Souto EB (2019) Current applications of NEs in cancer therapeutics. Nanomaterials (Basel, Switzerland) 9(6). https://doi.org/10.3390/NANO9060821
Sarfarazi M, Jafari SM, Rajabzadeh G (2015) Extraction optimization of saffron nutraceuticals through response surface methodology. Food Anal Methods 8(9):2273–2285. https://doi.org/10.1007/S12161-014-9995-3
Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, Sibai AM (2014) Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018. Popul Health Met 12(1):1–8. https://doi.org/10.1186/1478-7954-12-4/FIGURES/4
Sugumar S, Nirmala J, Ghosh V, Anjali H, Mukherjee A, Chandrasekaran N (2013) Bio-based NE formulation, characterization and antibacterial activity against food-borne pathogens. J Basic Microbiol 53(8):677–685. https://doi.org/10.1002/JOBM.201200060
Tao R, Wang CZ, Ye JZ, Zhou H, Chen HX, Zhang CW (2016) Antibacterial, cytotoxic and genotoxic activity of nitrogenated and haloid derivatives of C50-C60 and C70-C120 polyprenol homologs. Lipids Health Dis 15(1):1–11. https://doi.org/10.1186/S12944-016-0345-X
Tao R, Wang C, Zhang C, Li WJ, Zhou H, Chen H, Ye J (2018) Characterization, cytotoxicity, and genotoxicity of TiO2 and folate-coupled chitosan nanoparticles loading polyprenol-based NE. Biol Trace Elem Res 184(1):60–74. https://doi.org/10.1007/S12011-017-1184-Y
Upadhyay T, Ansari VA, Ahmad U, Sultana N, Akhtar J (2020) Exploring NE for liver cancer therapy. Curr Cancer Therapy Rev 16(4):260–268. https://doi.org/10.2174/1573394716666200302123336
Xu T, Gao CC, Feng X, Yang Y, Shen X, Tang X (2019) Structure, physical and antioxidant properties of chitosan-gum arabic edible films incorporated with cinnamon essential oil. Int J Biol Macromol 134:230–236. https://doi.org/10.1016/J.IJBIOMAC.2019.04.189
Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y (2016) Is conversion therapy possible in stage iv gastric cancer: the proposal of new biological categories of classification. Gastric Cancer: Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Associ 19(2):329–338. https://doi.org/10.1007/S10120-015-0575-Z
Zhang Y, Ding J, Sun D, Sun H, Zhuang X, Chang F, Wang J, Chen X (2015) Thermogel-mediated sustained drug delivery for in situ malignancy chemotherapy. Mater Sci Eng C, Mater Biol Appl 49:262–268. https://doi.org/10.1016/J.MSEC.2015.01.026
Zhang Y, Guan DX, Shi J, Gao H, Li JJ, Zhao JS, Qiu L, Liu J, Li N, Guo WX, Xue J, Zhou FG, Wu MC, Wang HY, Xie D, Cheng SQ (2013) All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer. J Hepatol 59(6):1255–1263. https://doi.org/10.1016/J.JHEP.2013.07.009
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yadav, S. et al. (2023). Treatment of Liver and Gastric Cancer Using Nanoemulsion. In: Husen, A., Bachheti, R.K., Bachheti, A. (eds) Current Trends in Green Nano-emulsions. Smart Nanomaterials Technology. Springer, Singapore. https://doi.org/10.1007/978-981-99-5398-1_11
Download citation
DOI: https://doi.org/10.1007/978-981-99-5398-1_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-5397-4
Online ISBN: 978-981-99-5398-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)